Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction

NCT05696223 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05696223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
June 1, 2022
Completion date
January 1, 2023
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.